THE government is investing a minimum of $2 billion to boost treated water coverage in Region Two, demonstrating the government’s mandate to provide...
Vous n'êtes pas connecté
Mezagitamab-Treated Patients Showed Rapid and Sustained Increases in Platelet Counts That Persisted 8 Weeks After the Last Dose Through to Week 161 Mezagitamab Had a Favorable Safety Profile, with No New Safety Signals1 Takeda Plans to Initiate Global Phase 3 Trial of Mezagitamab in ITP in the Second Half of FY2024 OSAKA, Japan & CAMBRIDGE, […]
THE government is investing a minimum of $2 billion to boost treated water coverage in Region Two, demonstrating the government’s mandate to provide...
CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...
OSAKA, Japan — Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the...
According to international media reports, Pakistan will initiate the second phase of the contentious expulsion of undocumented Afghan migrants. Al...
Imugene has confirmed the delivery of its first “onCARlytics” combination therapy dose to a bile duct cancer patient in the initial phase of a...
Man faces three counts of arson, as well a break and enter and mischief charges
In a continued effort to enhance community safety and reduce bear attractants, we are excited to announce the latest phase of a cost-share program...
The Southern African Music Rights Organisation (SAMRO) has successfully distributed a staggering R242 million for the Radio and General (R&G) Category...
EG 427, a biotechnology company leading the development of pinpoint DNA medicines for prevalent diseases in neurology based on its unique...
DAEJEON, South Korea, July 2, 2024. PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing...